---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-011901"
form_type: "8-K"
ticker: "HSDT"
cik: "0001610853"
company_name: "Solana Co"
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:03:21.426285+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Helius Medical Q2 revenue $182K (down 29% YoY); secures first insurance reimbursement for PoNS at $23,900

## Summary
- Revenue $182K vs $256K YoY due to PTAP termination; up 35% sequentially from Q1 2024.
- Net loss $1.6M flat YoY; EPS -$0.64 vs -$2.92; cash $6.4M, no debt, runway into 2025.
- First third-party insurance reimbursement secured at $23,900 for PoNS; CMS final rate due Oct 1.
- Completed enrollment in stroke registrational program; FDA submission targeted H1 2025.
- VA and DoD contract prices set at ~$23,800/$7,300 for device/mouthpiece; VA sales build underway.

## SEC filing metadata
- accession: 0001558370-24-011901
- form_type: 8-K
- ticker: HSDT
- cik: 0001610853
- company_name: Solana Co
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610853/000155837024011901/0001558370-24-011901-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610853/000155837024011901/hsdt-20240812x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-011901
- JSON: https://secwatch.observer/filing/0001558370-24-011901.json
- Plain text: https://secwatch.observer/filing/0001558370-24-011901.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.